 Decision analysis public health policy isoniazid chemoprophylaxis young adult tuberculin skin reactors part plan tuberculosis America tuberculin testing US citizens isoniazid chemopreventive therapy positive reactors Implementation plan concerns skin test reactors isoniazid therapy Recent decision contrary American Thoracic Society guidelines asymptomatic skin test reactors age years normal chest roentgenograms predisposing conditions reactivation isoniazid chemopreventive therapy analysis studies life expectancy estimates probability certain chance outcomes isoniazid-related hepatitis case-fatality rate isoniazid chemopreventive therapy beneficial literature review rate low tuberculosis case-fatality rate literature advantages isoniazid therapy repeated analysis physicians chemoprophylaxis tuberculin skin test reactors beneficial individual consonant public health policies